Ennov Welcomes Strategic Growth Investment from Bregal Sagemount and Ardian Growth

May 20, 2026

Ennov is pleased to announce a strategic growth investment led by Bregal Sagemount, with participation from Ardian Growth.

This investment marks an important step in Ennov’s continued growth as a global provider of unified Regulatory, Quality, Clinical, Commercial, and Pharmacovigilance software platform for life sciences. It will support Ennov’s next phase of expansion, with a focus on AI innovation, global go-to-market acceleration, and continued investment in the product offering.

For more than 25 years, Ennov has helped life sciences teams move away from fragmented systems and toward a unified compliance platform built for complex, regulated environments. Today, Ennov supports approximately 650 customers and more than 500,000 users across 30 countries.

With the support of Sagemount and Ardian, Ennov will continue to build on its mission of helping customers simplify compliance, connect critical processes, and prepare for the future of AI-enabled life sciences operations.

“We were looking for partners who understand the complexity of our customers’ environments and the opportunity ahead for integrated and AI-enabled software in life sciences,” said Olivier Pâris, Founder and CEO of Ennov. “Sagemount and Ardian bring that perspective, and we look forward to continuing to build innovative solutions that support our customers’ most critical processes.”

About Bregal Sagemount

Bregal Sagemount is a leading growth-focused private capital firm that provides flexible capital and strategic support to market-leading companies in high-growth sectors. With $11 billion of cumulative capital raised, Sagemount has invested in more than 90 companies across software, data and information services, financial technology, digital infrastructure, healthcare IT, and business services.

About Ardian

Ardian is a global private investment firm with 22 offices and more than 350 investment professionals worldwide. Managing or advising $200 billion for more than 1,920 clients, Ardian provides investment and customized solutions across Private Equity, Real Assets, and Credit, helping companies create long-term value in a changing world.

About Ennov

Ennov provides a comprehensive software platform to manage the most demanding processes of life sciences organizations in a compliant and efficient way. With over 25 years of experience, Ennov’s cloud-based solutions cover Regulatory Affairs, Pharmacovigilance, Quality, Clinical, and Document Management. Dedicated to innovation and excellence, Ennov’s solutions are used by more than 450 Life Science companies and 500,000 users worldwide, helping them to bring their products to market faster while maintaining compliance with regulatory requirements.

Share :

Facebook
Twitter
LinkedIn

Register for free to access to our library of exclusive content!